Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
anemia
Biotech
Akebia is taking the fight to the FDA months after rejection
Akebia is formally disputing FDA's decision to reject its anemia treatment, defending the treatment's risk-benefit profile.
Max Bayer
Nov 4, 2022 12:02pm
Akebia's anemia drug just misses in a COVID-19 trial
Aug 5, 2022 10:14am
After dispute, Otsuka pays Akebia $55M to exit anemia pill pacts
Jul 1, 2022 8:15am
Roivant decants another Vant armed with Eisai blood cancer drug
Feb 14, 2022 8:45am
GSK pulls off clean sweep of endpoint hits in anemia phase 3
Nov 8, 2021 7:25am
Mystery suitor lines up $11B Acceleron acquisition: report
Sep 27, 2021 7:10am
